谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Multiplex Analysis of the Immune Environment Before and after Neoadjuvant Durvalumab As a Prognostic Factor in Resectable Non-Small Cell Lung Cancer (NSCLC) in the IFCT-1601 IONESCO Phase 2 Trial.

Diane Damotte,Yoan Velut,Barbara Burroni, Gary Birsen, Julien Lavergne,Audrey Mansuet-Lupo, Isabelle Cremer,Julien Mazieres,Jacques Cadranel,Gerard Zalcman,Radj Gervais,Gaelle Jeannin,Olivier Molinier,Thomas Egenod,Olivier Carre, Celia Berndt,Alexandra Langlais,Franck Morin,Virginie Westeel,Marie Wislez

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要